Authors: Eric J. Topol, Akiko Iwasaki
Published: 2022-07-21
DOI: 10.1126/sciimmunol.add9947
Source: Full article
Given the poor ability of intramuscular mRNA COVID-19 vaccines to induce robust immunity in the respiratory mucosa, a push for a nasal vaccine strategy is needed.